What Does Manual Recoding Change in a Psychedelic Trial Registry Review?
A registry review depends on how records are classified. Uyar and colleagues examined 241 psychedelic-trial protocols using a search conducted on November 11, 2024. Their recoding procedures help explain how the published categories were produced.
Broad labels became more specific
Downloaded sponsor data distinguished industry from other sponsors. The reviewers manually separated categories including universities, industry, organizations, individual people and collaborations. A university category therefore required additional classification beyond the downloaded binary label.
Internal inconsistencies required interpretation
In five protocols, reviewers corrected the intervention-model classification after finding contradictions within or between registry sections. That describes their analytical treatment of records; it does not mean they changed the underlying trials or experimentally verified their conduct.
The review is a historical snapshot. Estimated completion dates for planned or ongoing studies are not receipts showing actual completion. Understanding its categories requires retaining both the snapshot date and the recoding decisions.
Source: Uyar A et al. (2026). Landscape analysis of pre-registered clinical trials involving classical psychedelics. DOI: 10.1177/02698811251371690.



